long term use semaglutide How Should You Maintain Treatment for Effective Weight Loss? Semaglutide GLP-1 Medical Weight Loss

Long-term safety data beyond 24 weeks is limited

Semaglutide (Ozempic/Wegovy) targets GLP-1 receptors to suppress appetite and improve metabolic function, while tirzepatide (Zepbound) takes treatment a step further with a dual-action mechanism that activates both GLP-1 and GIP receptors simultaneously

A 2024 review indicated that small pilot studies suggest GLP-1s can reduce some eating disorders, but researchers said more rigorously collected data is needed

Polynucleotides (PDRN) Polydeoxyribonucleotide injections to regenerate skin tissue, improve elasticity, and counteract the volume-loss effects of rapid weight reduction